The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Hepatitis Vaccines
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Hepatitis Vaccines.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Hepatitis Vaccines.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Hepatitis Vaccines are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
20. International Conference on Hepatitis Vaccines has teamed up with the Special Journal Issue on
Hepatitis Vaccines.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
Evaluation of the Hepatitis C Virus and Classical and Modern Immunoassays Used Nowadays to Diagnose It in Tirana
Stela Papa, Klementina Puto, Migena Pllaha
-
The Need for Including Hepatitis a Vaccine in Routine Childhood Immunization Programs in Europe as a Response to the Influx of Refugees from the Middle East and North Africa (MENA) Regions
S. Ramia, N. Melhem, K. Kreidieh
-
From Type-I to Type-II Fuzzy System Modeling for Diagnosis of Hepatitis
Shahabeddin Sotudian, M. H. Fazel Zarandi, I. B. Turksen
-
A Medical Resource Forecasting Model for Emergency Room Patients with Acute Hepatitis
R. J. Kuo, W. C. Cheng, W. C. Lien, T. J. Yang
-
Profile of Viral Hepatitis in Saudi Arabia
A. A. Alshabanat, R. B. Albacker, A. A. Basalama, A. A. Bin Salamah, A. S. Alfrayh
-
Impact of Hepatitis C Virus Chronic Infection on Quality of Life in Egypt
Ammal M. Metwally, Ghada A. Abdel-Latif, Walaa A. Fouad, Thanaa M. Rabah, Amira Mohsen, Fatma A. Shaaban, Iman I. Salama
-
Level of Behavioral Development for Hepatitis C Virus Cases versus Their Contacts: Does Infection Make a Difference and What Is Beyond?
Ammal M. Metwally, Lobna A. El Etreby, Rehan M. Saleh, Ghada Abdrabou, Somia I. Salama, Amira Orabi, Mohamed Abdelrahman
-
Characterization of Liver Leukocyte Infiltrates and Features of Cytokine Profile under Viral Hepatitis-Induced Immunosuppression
Olga V. Lebedinskaya, Irina N. Kabanovskaya, Anna S. Lasareva, Nelly K. Akhmatova, Anatoliy P. Godovalov, Andrey V. Horinko, Mikhail V. Kiselevsky
-
Sensitivity Comparison between Rapid Immuno-Chromatographic Device Test and ELISA in Detection and Sero-Prevalence of HBsAg and Anti-HCV antibodies in Apparently Healthy Blood Donors of Lahore, Pakistan
Natasha Hussain, Maleeha Aslam, Robina Farooq
-
The Prevalence of Transfusion-Transmitted Virus (TTV) Infection inIranian Patients with Chronic Hepatitis B
P. Ghasemi Dehkordi, A. Doosti, M. R. Hajimirzaei
-
A Study of Liver Checkup in Patients with Hepatitis C in the Region of Batna
A. Zidani, M. Yahia K. Belhadi, S. Benbia
-
Artificial Intelligence Support for Interferon Treatment Decision in Chronic Hepatitis B
Alexandru George Floares
Conference venue information will be released soon.
Hepatitis C Vaccine
Hepatitis B Vaccine
Hepatitis A Vaccine
Hepatitis Vaccines Trials
Human vaccines infectious and non-infectious
Vaccines emerging and re-emerging diseases: flu, ebola, HIV and malaria
Modern technologies in vaccine discovery and development
Recent trends in attenuated vaccines
Developing next-gen conjugate vaccines
Veterinary vaccines
Virus-like particle vaccines :applications
Advancements in vaccine development
Vaccines safety and schedule
Respiratory disease vaccines
Vaccines for child and pregnant women
Adjuvants for human/ animal vaccines—current status, problems and future prospects
Toxoid vaccines and its importance
Vaccines under research and development, major diseases
Delivery technologies
Immunology/animal models
Dna vaccines
Vaccine and retro viral diseases
Vaccines business and market analysis
Age-specific immune response to vaccination
Production, manufacturing and safety
Vaccinations and immunization practices
Mucosal vaccines
Abstracts/Full-Text Paper Submission Deadline |
|
February 13, 2025 |
Notification of Acceptance/Rejection |
|
February 27, 2025 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
July 22, 2026 |
Conference Dates |
|
August 23-24, 2026 |